Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
80
datasets available to search
ShareScore release 0.9.0
Dataset results
80 results for “CIC”
Dataset for "On the potential of the Cluster Ion Counter (CIC) to observe local new particle formation, condensation sink and growth rate of newly formed particles"
<p>Data for Kulmala et al. (2024 )"On the potential of the Cluster Ion Counter (CIC) to observe local new particle formation, condensation sink and growth rate of newly formed particles" (https://doi.org/10.5194/ar-2024-14).</p> <p>Included in the file are number concentrations of sub-2 nm ions and 2-2.3 nm ions measured with Cluster Ion Counter (CIC) and Neutral cluster and Air Ion Spectrometer (NAIS) at SMEAR II station in Hyytiälä, Finland. Concentrations of 1-2 nm ions measured with the NAIS are also included. Sub-2 nm (2-2.3 nm) ion concentrations measured with CIC are refered as Channel 1 (Channel 2-Channel 3) in the .csv file.</p> <p>Contact Santeri Tuovinen (santeri.tuovinen@helsinki.fi) for more details.</p>
Transcriptomic Analysis of CIC and CTC from Tumor Bearing Mice
<p>CIC and CTC isolated from tumor bearing mice were subjected to transcriptomic analysis using Smart-seq3 library preparation method. n = 3 for each group. </p>
12-Week Study of Plecanatide for CIC (The National CIC3 Study)
ClinicalTrials.gov study NCT02122471. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
ClinicalTrials.gov study NCT01919697. IPD Sharing: Not stated. Countries: 2. Publications: 1.
12-Week Study of Plecanatide for CIC (The CIC3 Study)
ClinicalTrials.gov study NCT01982240. IPD Sharing: Not stated. Countries: 2. Publications: 5.
Metabolic Balance Study of Apraglutide in Patients With Short Bowel Syndrome, Intestinal Failure (SBS-IF) and Colon-in-Continuity (CIC)
ClinicalTrials.gov study NCT04964986. IPD Sharing: Not stated. Countries: 2. Publications: 1.
CIC-IDS-2017 V2
<p>The CIC-IDS-V2 is an extended version of the original CIC-IDS 2017 dataset. The dataset is normalised and 1 new class called "Comb" is added which is a combination of synthesised data of multiple non-benign classes.</p> <p>To cite the dataset, please reference the original paper with DOI: 10.1109/SmartNets61466.2024.10577645. The paper is published in IEEE SmartNets and can be accessed <a href="https://www.researchgate.net/publication/382034618_Blender-GAN_Multi-Target_Conditional_Generative_Adversarial_Network_for_Novel_Class_Synthetic_Data_Generation" target="_blank" rel="noopener">here</a>.</p> <p>Citation info:</p> <p>Madhubalan, Akshayraj & Gautam, Amit & Tiwary, Priya. (2024). Blender-GAN: Multi-Target Conditional Generative Adversarial Network for Novel Class Synthetic Data Generation. 1-7. 10.1109/SmartNets61466.2024.10577645. </p> <p>This dataset was made by <a href="https://www.abluva.com" target="_blank" rel="noopener">Abluva Inc,</a> a Palo Alto based, research-driven Data Protection firm. Our data protection platform empowers customers to secure data through advanced security mechanisms such as Fine Grained Access control and sophisticated depersonalization algorithms (e.g. Pseudonymization, Anonymization and Randomization). Abluva's Data Protection solutions facilitate data democratization within and outside the organizations, mitigating the concerns related to theft and compliance. The innovative intrusion detection algorithm by Abluva employs patented technologies for an intricately balanced approach that excludes normal access deviations, ensuring intrusion detection without disrupting the business operations. Abluva’s Solution enables organizations to extract further value from their data by enabling secure Knowledge Graphs and deploying Secure Data as a Service among other novel uses of data. Committed to providing a safe and secure environment, Abluva empowers organizations to unlock the full potential of their data.</p>
CSE-CIC-IDS2018 V2
<p>This is the updated version CSE-CIC-IDS 2018 dataset. The data is normalised and 1 new class "Comb" which is a combination of existing attacks is added. </p> <p>To cite the dataset, please reference the original paper with DOI: 10.1109/SmartNets61466.2024.10577645. The paper is published in IEEE SmartNets and can be accessed <a href="https://www.researchgate.net/publication/382034618_Blender-GAN_Multi-Target_Conditional_Generative_Adversarial_Network_for_Novel_Class_Synthetic_Data_Generation" target="_blank" rel="nofollow noopener noreferrer">here</a>.</p> <p>Citation info:</p> <p>Madhubalan, Akshayraj & Gautam, Amit & Tiwary, Priya. (2024). Blender-GAN: Multi-Target Conditional Generative Adversarial Network for Novel Class Synthetic Data Generation. 1-7. 10.1109/SmartNets61466.2024.10577645. </p> <p>This dataset was made by <a href="https://www.abluva.com" target="_blank" rel="noopener">Abluva Inc,</a> a Palo Alto based, research-driven Data Protection firm. Our data protection platform empowers customers to secure data through advanced security mechanisms such as Fine Grained Access control and sophisticated depersonalization algorithms (e.g. Pseudonymization, Anonymization and Randomization). Abluva's Data Protection solutions facilitate data democratization within and outside the organizations, mitigating the concerns related to theft and compliance. The innovative intrusion detection algorithm by Abluva employs patented technologies for an intricately balanced approach that excludes normal access deviations, ensuring intrusion detection without disrupting the business operations. Abluva’s Solution enables organizations to extract further value from their data by enabling secure Knowledge Graphs and deploying Secure Data as a Service among other novel uses of data. Committed to providing a safe and secure environment, Abluva empowers organizations to unlock the full potential of their data.</p>
Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma
ClinicalTrials.gov study NCT04293289. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Importance of Carrier Status of Recessive Gene Mutations in Myopathy (CICS)
ClinicalTrials.gov study NCT02897921. IPD Sharing: NO. Countries: 1. Publications: 3.
CIC Behavioral Economics in Children With Spina Bifida
ClinicalTrials.gov study NCT05562713. IPD Sharing: NO. Countries: 1. Publications: 4.
Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)
ClinicalTrials.gov study NCT06904872. IPD Sharing: NO. Countries: 2. Publications: 26.
The Detection of Cell-in-cell Structure (CICs) in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT05642104. IPD Sharing: UNDECIDED. Countries: 1. Publications: 8.
Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma.
ClinicalTrials.gov study NCT00392288. IPD Sharing: Not stated. Countries: 6. Publications: 0.
BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma
ClinicalTrials.gov study NCT06414434. IPD Sharing: YES. Countries: 1. Publications: 0.
Efficacy and Safety of Vibrant Capsule vs. Vibrant Placebo for the Treatment of Chronic Idiopathic Constipation (CIC)
ClinicalTrials.gov study NCT04458675. IPD Sharing: NO. Countries: 1. Publications: 0.
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
ClinicalTrials.gov study NCT01429987. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Clean Intermittent Catheterization (CIC) in Multiple Sclerosis (MS) Patients With Bladder Dysfunction
ClinicalTrials.gov study NCT00913510. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Efficacy of Linaclotide to Senna for CIC
ClinicalTrials.gov study NCT02239510. IPD Sharing: NO. Countries: 1. Publications: 0.
Disruption of the ATXN1-CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humans
GEO Series GSE83243. Mus musculus. 8 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.